These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 38705510)

  • 21. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
    Nestor MS; Ablon G; Gade A; Han H; Fischer DL
    J Cosmet Dermatol; 2021 Dec; 20(12):3759-3781. PubMed ID: 34741573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
    Gupta AK; Talukder M; Shemer A
    Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia.
    Premanand A; Reena Rajkumari B
    Arch Dermatol Res; 2018 Jul; 310(5):391-399. PubMed ID: 29549490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New investigational drugs for androgenetic alopecia.
    Valente Duarte de Sousa IC; Tosti A
    Expert Opin Investig Drugs; 2013 May; 22(5):573-89. PubMed ID: 23550739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways.
    Abdin R; Zhang Y; Jimenez JJ
    Front Med (Lausanne); 2022; 9():843127. PubMed ID: 35372424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular Senescence: Ageing and Androgenetic Alopecia.
    Deng Y; Wang M; He Y; Liu F; Chen L; Xiong X
    Dermatology; 2023; 239(4):533-541. PubMed ID: 37088073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia.
    Gupta AK; Carviel J
    Dermatol Surg; 2016 Dec; 42(12):1335-1339. PubMed ID: 27631460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?
    Shoemaker TJ; Kono T; Mariash CN; Evans-Molina C
    Endocr Pract; 2012; 18(6):954-64. PubMed ID: 22784847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review: The platelet-rich plasma use in female androgenetic alopecia as effective autologous treatment of regenerative plastic surgery.
    Gentile P; Garcovich S
    J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):850-859. PubMed ID: 34872877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.
    Meidan VM; Touitou E
    Drugs; 2001; 61(1):53-69. PubMed ID: 11217871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgenetic alopecia.
    Piraccini BM; Alessandrini A
    G Ital Dermatol Venereol; 2014 Feb; 149(1):15-24. PubMed ID: 24566563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgenetic alopecia: pathogenesis and potential for therapy.
    Ellis JA; Sinclair R; Harrap SB
    Expert Rev Mol Med; 2002 Nov; 4(22):1-11. PubMed ID: 14585162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the development of agonists selective for beta1-type thyroid hormone receptor.
    Malm J; Grover GJ; Färnegårdh M
    Mini Rev Med Chem; 2007 Jan; 7(1):79-86. PubMed ID: 17266640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current management of androgenetic alopecia in men.
    Wolff H; Kunte C
    Eur J Dermatol; 1999 Dec; 9(8):606-9. PubMed ID: 10586125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell Therapy for Androgenetic Alopecia: Elixir or Trick?
    Mao Y; Liu P; Wei J; Xie Y; Zheng Q; Li R; Yao J
    Stem Cell Rev Rep; 2023 Aug; 19(6):1785-1799. PubMed ID: 37277541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review.
    Zubair Z; Kantamaneni K; Jalla K; Renzu M; Jena R; Jain R; Muralidharan S; Yanamala VL; Alfonso M
    Cureus; 2021 Dec; 13(12):e20431. PubMed ID: 35047268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgenetic alopecia: An update.
    Ntshingila S; Oputu O; Arowolo AT; Khumalo NP
    JAAD Int; 2023 Dec; 13():150-158. PubMed ID: 37823040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug discovery for alopecia: gone today, hair tomorrow.
    Santos Z; Avci P; Hamblin MR
    Expert Opin Drug Discov; 2015 Mar; 10(3):269-92. PubMed ID: 25662177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.